RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Cost-effectiveness of nationwide opportunistic screening program for dementia in South Korea

J Alzheimers Dis 44(1):195-204 · 2015 · PMID 25208621

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

176편 검색→172편 판독→34편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Cost-effectiveness of dementia screening and early diagnosis (("cost-effectiveness"[tiab] OR "cost effectiveness"[tiab] OR "economic evaluation"[tiab] OR "cost-utility"[tiab] OR "cost utility"[tiab] OR "cost-benefit"[tiab] OR "cost benefit"[tiab]) AND (dementia[tiab] OR "Alzheimer disease"[tiab] OR "Alzheimer's disease"[tiab] OR "cognitive impairment"[tiab] OR "mild cognitive impairment"[tiab]) AND (screening[tiab] OR "early diagnosis"[tiab] OR "early detection"[tiab] OR "case finding"[tiab] OR "population screening"[tiab]))

출판 연도

1994: 1편119941999: 2편2200020052009: 3편320102011: 1편12012: 2편22013: 1편12014: 2편22015: 2편220152017: 1편12018: 1편12020: 1편120202021: 2편22022: 2편22023: 3편32024: 2편22025: 6편62026: 2편22026

선별된 34편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01costs · model18편

  1. 0.96

    Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care

    Tong T, Thokala P, McMillan B et al. · International journal of geriatric psychiatry · 2017

  2. 0.95

    Health economic analysis of the integrated cognitive assessment tool to aid dementia diagnosis in the United Kingdom

    Shore J, Kalafatis C, Stainthorpe A et al. · Frontiers in public health · 2023

  3. 0.95

    Cost-effectiveness of nationwide opportunistic screening program for dementia in South Korea 이 논문

    Yu SY, Lee TJ, Jang SH et al. · Journal of Alzheimer's disease : JAD · 2015

  4. 0.95

    Economic evaluation of the screening for Alzheimer's disease in China

    Ren Y, Zhou D, Xing Q et al. · Frontiers in aging neuroscience · 2022

  5. 0.94

    Cost-effectiveness of 5-Cog paradigm for individuals with cognitive concerns in primary care

    Congivaram H, Walker J, Ayers E et al. · Public health · 2025

  6. 0.93

    Exploring the cost-effectiveness of a one-off screen for dementia (for people aged 75 years in England and Wales)

    Dixon J, Ferdinand M, D'Amico F et al. · International journal of geriatric psychiatry · 2015

  7. 0.92

    Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS

    van Maurik IS, Altomare D, Collij LE et al. · European journal of neurology · 2025

  8. 0.89

    The costs and benefits of a screening program to detect dementia in older drivers

    Retchin SM, Hillner BE · Medical decision making : an international journal of the Society for Medical Decision Making · 1994

  9. 0.89

    A preliminary economic evaluation of a potential program for the primary prevention of Alzheimer's disease

    Mattke S, Chen J, Reiman EM · The journal of prevention of Alzheimer's disease · 2025

  10. 0.89

    Clinical and cost effectiveness of services for early diagnosis and intervention in dementia

    Banerjee S, Wittenberg R · International journal of geriatric psychiatry · 2009

  11. 0.88

    Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation

    Budd D, Burns LC, Guo Z et al. · ClinicoEconomics and outcomes research : CEOR · 2011

  12. 0.86

    Cognitive impairment screening strategy to reduce the burden of Alzheimer's disease in Shanghai: A system dynamics approach

    Zang GY, Rao K, Wu ATY et al. · Journal of Alzheimer's disease reports · 2025

  13. 0.85

    The use of CT scanning in dementia. A systematic review

    Foster GR, Scott DA, Payne S · International journal of technology assessment in health care · 1999

  14. 0.85

    Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicine

    Djalalov S, Yong J, Beca J et al. · Molecular diagnosis & therapy · 2012

  15. 0.84

    Early identification and treatment of Alzheimer's disease: social and fiscal outcomes

    Weimer DL, Sager MA · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2009

  16. 0.78

    Health Economic Considerations in the Deployment of an Alzheimer's Prevention Therapy

    Mattke S, Jun H, Hanson M et al. · The journal of prevention of Alzheimer's disease · 2024

  17. 0.53

    Dementia. Improve care through a pathway to early diagnosis

    Shepherd S · The Health service journal · 2009

  18. 0.52

    An economic perspective on Alzheimer's disease

    Trabucchi M · Journal of geriatric psychiatry and neurology · 1999

02alzheimer disease · diagnostic9편

  1. 0.96

    Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study

    Leelahavarong P, Prawjaeng J, Angkab P et al. · BMC health services research · 2026

  2. 0.94

    Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease

    Biasutti M, Dufour N, Ferroud C et al. · PloS one · 2012

  3. 0.94

    Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease

    Valcarcel-Nazco C, Perestelo-Perez L, Molinuevo JL et al. · Journal of Alzheimer's disease : JAD · 2014

  4. 0.93

    Are diagnostic technologies for alzheimer's disease and dementia cost-effective? A systematic review of economic evaluations

    Kashem M, Haldenby O, Ahmad JF et al. · Alzheimer's research & therapy · 2026

  5. 0.93

    Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment RECODE

    Lee YS, Youn H, Jeong HG et al. · Cost effectiveness and resource allocation : C/E · 2021

  6. 0.86

    Cost-effectiveness of Alzheimer's disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis

    Contador J, Vargas-Martinez AM, Sanchez-Valle R et al. · European archives of psychiatry and clinical neuroscience · 2023

  7. 0.84

    Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis

    Noda K, Lim Y, Goto R et al. · Drug discovery today · 2024

  8. 0.78

    Early detection of cognitive impairment in the elderly based on Bayesian mining using speech prosody and cerebral blood flow activation

    Kato S, Endo H, Homma A et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2013

  9. 0.52

    Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease

    Chang HI, Ma MC, Huang KL et al. · Alzheimer's research & therapy · 2025

03examination · mmse3편

  1. 0.92

    Cost-benefit and discriminant validity of a stepwise dementia case-finding approach in an Asian older adult community

    Pang T, Xia B, Zhao X et al. · General psychiatry · 2023

  2. 0.77

    Deep learning based low-cost high-accuracy diagnostic framework for dementia using comprehensive neuropsychological assessment profiles RECODE

    Choi HS, Choe JY, Kim H et al. · BMC geriatrics · 2018

  3. 0.56

    Validation of the Informant Quick Dementia Rating System (QDRS) among Older Adults in Singapore

    Pang T, Chong EJY, Wong ZX et al. · Journal of Alzheimer's disease : JAD · 2022

04trial registration · controlled2편

  1. 0.70

    Dementia screening for elderly in-patients and its association with nursing care satisfaction-an observational study

    Huang LK, Tsai JC, Lee HH et al. · Medicine · 2020

  2. 0.56

    Improving Early Dementia Detection Among Diverse Older Adults With Cognitive Concerns With the 5-Cog Paradigm: Protocol for a Hybrid Effectiveness-Implementation Clinical Trial

    Chalmer RBR, Ayers E, Weiss EF et al. · JMIR research protocols · 2025

05review · risk1편

  1. 0.69

    Diagnosing Alzheimer's disease: a systematic review of economic evaluations

    Handels RLH, Wolfs CAG, Aalten P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

06alzheimer disease · biomarkers1편

  1. 0.62

    Head-to-head comparison of amplified plasmonic exosome Abeta42 platform and single-molecule array immunoassay in a memory clinic cohort

    Tanaka T, Ruifen JC, Nai YH et al. · European journal of neurology · 2021